Global Zebrafish for Biotech Market Growth (Status and Outlook) 2025-2031

The global Zebrafish for Biotech market size is predicted to grow from US$ 28.3 million in 2025 to US$ 74.4 million in 2031; it is expected to grow at a CAGR of 17.5% from 2025 to 2031.

United States market for Zebrafish for Biotech is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Zebrafish for Biotech is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Zebrafish for Biotech is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Zebrafish for Biotech players cover Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Zebrafish for Biotech Industry Forecast” looks at past sales and reviews total world Zebrafish for Biotech sales in 2024, providing a comprehensive analysis by region and market sector of projected Zebrafish for Biotech sales for 2025 through 2031. With Zebrafish for Biotech sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Zebrafish for Biotech industry.

This Insight Report provides a comprehensive analysis of the global Zebrafish for Biotech landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Zebrafish for Biotech portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Zebrafish for Biotech market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Zebrafish for Biotech and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Zebrafish for Biotech.

This report presents a comprehensive overview, market shares, and growth opportunities of Zebrafish for Biotech market by product type, application, key players and key regions and countries.

Segmentation by Type:
Toxicity Testing Services
Transgenesis and Gene Editing Services
Disease Models
Others

Segmentation by Application:
Biotechnology Companies
Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shanghai Model Organisms Center, Inc.
ZeClinics
InVivo Biosystems
Biobide
Pentagrit
Evotec
Aurigene Pharmaceutical Services
ikanbiotech
Bioreperia
Hangzhou Hunter Biotechnology Co., Ltd.
YSY BIOTECH
Eze-Rinka
INVENesis
FEIFAN TEST
Charles River Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.